{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:11:48Z","timestamp":1760055108693,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma SAS","doi-asserted-by":"publisher","award":["AS01\/13"],"award-info":[{"award-number":["AS01\/13"]}],"id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.medmal.2015.04.009","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T19:52:57Z","timestamp":1433620377000},"page":"293-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France"],"prefix":"10.1016","volume":"45","author":[{"given":"M.","family":"Auzou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Poyart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"Ploy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cattoir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2015.04.009_bib0080","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/AAC.44.6.1453-1457.2000","article-title":"Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients","volume":"44","author":"Bingen","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2015.04.009_bib0085","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/AAC.48.9.3559-3562.2004","article-title":"Emergence of macrolide-resistant Streptococcus pyogenes strains in French children","volume":"48","author":"Bingen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2015.04.009_bib0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jac\/48.2.291","article-title":"Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France","volume":"48","author":"Weber","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2015.04.009_bib0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijmm.2012.09.001","article-title":"Decline in macrolide-resistant Streptococcus pyogenes isolates from French children","volume":"302","author":"d\u2019Humieres","year":"2012","journal-title":"Int J Med Microb"},{"key":"10.1016\/j.medmal.2015.04.009_bib0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2015.04.009_bib0105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1198-743x.2001.00280.x","article-title":"In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995\u20131999","volume":"7","author":"Schlegel","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2015.04.009_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/dkg039","article-title":"Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics","volume":"51","author":"Sauermann","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2015.04.009_bib0115","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/jac\/dkm089","article-title":"Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae","volume":"59","author":"Mazzariol","year":"2007","journal-title":"J Antimicrob Chemother"},{"year":"2008","series-title":"Approved standard, CLSI document M7-A8 methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"CLSI","key":"10.1016\/j.medmal.2015.04.009_bib0120"},{"key":"10.1016\/j.medmal.2015.04.009_bib0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijantimicag.2010.10.008","article-title":"Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus saprophyticus clinical isolates","volume":"37","author":"Le Bouter","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2015.04.009_bib0130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jac\/42.6.729","article-title":"Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates","volume":"42","author":"Klugman","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2015.04.009_bib0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/QCO.0b013e3283458f7e","article-title":"New understandings in Streptococcus pyogenes","volume":"24","author":"Lynskey","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.medmal.2015.04.009_bib0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.9.3.546","article-title":"In vitro susceptibility studies with josamycin and erythromycin","volume":"9","author":"Strausbaugh","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2015.04.009_bib0145","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/AAC.32.11.1710","article-title":"Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides","volume":"32","author":"Hardy","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.medmal.2015.04.009_bib0150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/AAC.46.5.1199-1203.2002","article-title":"Emergence of group A Streptococcus strains with different mechanisms of macrolide resistance","volume":"46","author":"Bingen","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X15001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X15001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:13:53Z","timestamp":1759972433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X15001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0399077X15001183"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2015.04.009","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2015.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}